Abstract:Background Previous research has found that multi-drug resistant (MDR) bacteria can be transmitted between ICU patients, and the infections caused by MDR bacteria may negatively affect the efficacy of current treatment. As the speed of diagnostic testing to identify MDR bacteria is relatively slow in clinical practice, the research regarding the prediction of MDR bacteria infections has developed. Objective To develop an evidence-based risk prediction model for MDR bacterial infections in ICU patients, and to verify it using the real-world clinical data collected retrospectively. Methods Potential risk factors for MDR bacterial infections in ICU patients were identified by a meta-analysis of studies regarding MDR bacterial infections in ICU patients included in databases of PubMed, EMBase, the Cochrane Library, CNKI, Wanfang, China Science and Technology Journal Database, Ace Base of CMA during January 2012 to June 2020 using Stata/SE 12.0 software, and were used to develop a risk prediction model by transforming effect size to the standardized regression (β) coefficient. Next the model was fully established and externally verified using the clinical data of adult ICU patients (n=3 908) recruited from Shanghai General Hospital from January 2018 to June 2021. ROC analysis was used to describe the predictive accuracy of the prediction model. Results Seventeen potential risk factors of MDR bacterial infections in ICU patients were identified through the meta-analysis of 31 included studies. The MDR bacterial infection risk prediction model incorporating these 17 factors with corresponding β value as coefficient (derived from converting the risk effect size of each factor) was developed: Logit (P) =-2.476 3 +0.086X1〔gender (male) 〕+0.191X2 (history of hospitalization) +0.392X3 (being transferred from another hospital) +1.723X4 (length of ICU stay) +0.315X5 (other infections) +0.385X6 (chronic obstructive pulmonary disease) +0.131X7 (diabetes) +0.536X8 (renal disease) +0.285X9 (renal failure) +0.565X10 (dialysis) +0.148X11 (mechanical ventilation) +0.742X12 (central venous catheter) +0.336X13 (urinary catheter) +3.483X14 (types of used antimicrobial drugs) +0.174X15 (history of antimicrobial use) +0.975X16 (history of carbapenems use) +1.151X17 (history of aminoglycosides use) . External verification of the model revealed that the model had 64.36% sensitivity, 80.39% specificity, and 0.447 4 Youden index, and an AUC of 0.724. Conclusion Our model has been proved to have good performance in predicting the MDR bacterial infection risk in ICU patients, as well as relatively good applicability, scientificity, and practicability. The development regimen may be used as a reference for developing a risk prediction model for other diseases.

Construction of a prediction model for pulmonary infection and its risk factors in Intensive Care Unit patients

Clinical Characteristics Analysis and Construction of a Predictive Diagnostic Model of Community-Acquired Pneumonia in Adults Requiring Hospitalization in Fujian Provincial Hospital

A Risk Prediction Model for Efficient Intubation in the Emergency Department: A Five-Year Single-Center Retrospective Analysis

The Incidence And Risk Factors Of Nosocomial Infections In Intensive Care Unit In China: An Epidemiological Study Of 1718 Patients

Construction and evaluation of a risk prediction model for pulmonary infection‐associated acute kidney injury in intensive care units

Development and Validation of Nomogram for Hospital Mortality in Immunocompromised Patients with Severe Pneumonia in Intensive Care Units: A Single-Center, Retrospective Cohort Study

Multi-omics and Immune Cells’ Profiling of COVID-19 Patients for ICU Admission Prediction: in Silico Analysis and an Integrated Machine Learning-Based Approach in the Framework of Predictive, Preventive, and Personalized Medicine

Risk stratification and survival time of patients with gram-negative bacillary pneumonia in the intensive care unit

Risk factor analysis and nomogram for predicting in-hospital mortality in ICU patients with sepsis and lung infection

Clinical Characteristics and Risk Factors Associated with ICU-acquired Infections in Sepsis: A Retrospective Cohort Study

Exploiting an Early Warning Nomogram for Predicting the Risk of ICU Admission in COVID-19 patients: A Multi-Center Study in China

Development and evaluation of a model for predicting the risk of healthcare-associated infections in patients admitted to intensive care units

Risk factors analysis and prediction model construction for severe pneumonia in older adult patients

Development and External Validation of an Evidence-based Risk Prediction Model for Multidrug-resistant Bacterial Infections in ICU Patients

Development and validation of a predictive model for pulmonary infection risk in patients with traumatic brain injury in the ICU: a retrospective cohort study based on MIMIC-IV

Development and validation of a nomogram for predicting pulmonary infection in patients receiving immunosuppressive drugs

Development and validation of a prediction model for in-hospital mortality in patients with sepsis

Exploiting an early warning Nomogram for predicting the risk of ICU admission in patients with COVID-19: a multi-center study in China

Risk factors and predictive model for nosocomial infections by extensively drug-resistant Acinetobacter baumannii

Development and validation of a nomogram for predicting pulmonary infections after Intracerebral hemorrhage in elderly people

Evaluating the Efficiency of a Nomogram Based on the Data of Neurosurgical Intensive Care Unit Patients to Predict Pulmonary Infection of Multidrug-Resistant Acinetobacter Baumannii.